BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Papanota AM, Tsiakanikas P, Kontos CK, Malandrakis P, Liacos CI, Ntanasis-Stathopoulos I, Kanellias N, Gavriatopoulou M, Kastritis E, Avgeris M, Dimopoulos MA, Scorilas A, Terpos E. A Molecular Signature of Circulating MicroRNA Can Predict Osteolytic Bone Disease in Multiple Myeloma. Cancers (Basel) 2021;13:3877. [PMID: 34359778 DOI: 10.3390/cancers13153877] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Sharma AR, Lee YH, Lee SS. Recent advancements of miRNAs in the treatment of bone diseases and their delivery potential. Curr Res Pharmacol Drug Discov 2023;4:100150. [PMID: 36691422 DOI: 10.1016/j.crphar.2022.100150] [Reference Citation Analysis]
2 Zhang B, Bian B, Zhang Y, Zhang L, Zhang R, Wang J. The Apparent Diffusion Coefficient of Diffusion-Weighted Whole-Body Magnetic Resonance Imaging Affects the Survival of Multiple Myeloma Independently. Front Oncol 2022;12:780078. [DOI: 10.3389/fonc.2022.780078] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 张 蕊. Research about Early Diagnosis Strategy in Renal Impairment Due to Multiple Myeloma. ACM 2022;12:4770-4775. [DOI: 10.12677/acm.2022.125692] [Reference Citation Analysis]
4 Hu T, Huang S, Lv X, Wang S, Getachew T, Mwacharo JM, Haile A, Sun W. miR-143 Targeting CUX1 to Regulate Proliferation of Dermal Papilla Cells in Hu Sheep. Genes (Basel) 2021;12:2017. [PMID: 34946965 DOI: 10.3390/genes12122017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
5 Papanota AM, Karousi P, Kontos CK, Artemaki PI, Liacos CI, Papadimitriou MA, Bagratuni T, Eleutherakis-Papaiakovou E, Malandrakis P, Ntanasis-Stathopoulos I, Gavriatopoulou M, Kastritis E, Avgeris M, Dimopoulos MA, Scorilas A, Terpos E. A Cancer-Related microRNA Signature Shows Biomarker Utility in Multiple Myeloma. Int J Mol Sci 2021;22:13144. [PMID: 34884950 DOI: 10.3390/ijms222313144] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Karousi P, Papanota AM, Artemaki PI, Liacos CI, Patseas D, Mavrianou-Koutsoukou N, Liosi AA, Kalioraki MA, Ntanasis-Stathopoulos I, Gavriatopoulou M, Kastritis E, Dimopoulos MA, Scorilas A, Terpos E, Kontos CK. tRNA Derivatives in Multiple Myeloma: Investigation of the Potential Value of a tRNA-Derived Molecular Signature. Biomedicines 2021;9:1811. [PMID: 34944627 DOI: 10.3390/biomedicines9121811] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Moura SR, Abreu H, Cunha C, Ribeiro-Machado C, Oliveira C, Barbosa MA, Marques H, Almeida MI. Circulating microRNAs Correlate with Multiple Myeloma and Skeletal Osteolytic Lesions. Cancers (Basel) 2021;13:5258. [PMID: 34771422 DOI: 10.3390/cancers13215258] [Reference Citation Analysis]